A detailed history of Glen Eagle Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 131 shares of DHR stock, worth $34,870. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131
Holding current value
$34,870
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $4,474 - $5,091
19 Added 16.96%
131 $32.7 Million
Q1 2024

Jul 03, 2024

BUY
$224.58 - $256.19 $25,152 - $28,693
112 New
112 $28 Million
Q4 2023

Aug 13, 2024

SELL
$185.1 - $233.13 $555 - $699
-3 Reduced 2.61%
112 $25.9 Million
Q1 2023

Aug 13, 2024

BUY
$239.75 - $277.0 $3,356 - $3,878
14 Added 13.86%
115 $29 Million
Q4 2022

Aug 13, 2024

BUY
$241.42 - $282.29 $2,897 - $3,387
12 Added 13.48%
101 $26.8 Million
Q2 2022

Aug 13, 2024

BUY
$237.11 - $299.66 $12,566 - $15,881
53 Added 147.22%
89 $22.6 Million
Q4 2020

Aug 13, 2024

SELL
$212.5 - $245.46 $16,150 - $18,654
-76 Reduced 67.86%
36 $8 Million
Q1 2020

Aug 13, 2024

BUY
$121.39 - $169.05 $9,104 - $12,678
75 Added 208.33%
111 $15.4 Million
Q3 2019

Aug 13, 2024

SELL
$135.4 - $146.47 $135 - $146
-1 Reduced 2.7%
36 $5.2 Million
Q2 2019

Aug 13, 2024

SELL
$124.88 - $143.73 $124 - $143
-1 Reduced 2.63%
37 $5.29 Million
Q1 2019

Aug 13, 2024

SELL
$97.62 - $132.29 $7,223 - $9,789
-74 Reduced 66.07%
38 $5.02 Million
Q4 2018

Aug 13, 2024

BUY
$94.85 - $109.54 $948 - $1,095
10 Added 18.52%
64 $6.6 Million
Q3 2018

Aug 13, 2024

SELL
$98.13 - $108.9 $5,691 - $6,316
-58 Reduced 51.79%
54 $5.87 Million
Q1 2017

Aug 12, 2024

SELL
N/A
-2 Reduced 2.15%
91 $7.78 Million
Q4 2016

Aug 12, 2024

SELL
N/A
-19
93 $7.24 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $194B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.